<!DOCTYPE html>
<html lang="en-us"
  dir="ltr">

<head>
  <meta charset="utf-8">
<meta name="viewport" content="width=device-width">



<link rel="icon" type="image/ico" href="https://reports.muthu.co/favicon.ico">
<link rel="icon" type="image/png" sizes="16x16" href="https://reports.muthu.co/favicon-16x16.png">
<link rel="icon" type="image/png" sizes="32x32" href="https://reports.muthu.co/favicon-32x32.png">
<link rel="icon" type="image/png" sizes="192x192" href="https://reports.muthu.co/android-chrome-192x192.png">
<link rel="apple-touch-icon" sizes="180x180" href="https://reports.muthu.co/apple-touch-icon.png">

<meta name="description" content=""/>



<title>
    
    Dhanuka Agritech Ltd - May 2025 Earnings Call Transcript Analysis | Financial Report Insights
    
</title>
<link href="/pagefind/pagefind-ui.css" rel="stylesheet">
<script src="/pagefind/pagefind-ui.js"></script>
<link rel="canonical" href="https://reports.muthu.co/posts/dhanuka-agritech-ltd---may-2025-earnings-call-transcript-analysis/"/>

<meta property="og:url" content="https://reports.muthu.co/posts/dhanuka-agritech-ltd---may-2025-earnings-call-transcript-analysis/">
  <meta property="og:site_name" content="Financial Report Insights">
  <meta property="og:title" content="Dhanuka Agritech Ltd - May 2025 Earnings Call Transcript Analysis">
  <meta property="og:description" content="Earnings Call Transcript Analysis Report # Financial Performance # Key Financial Metrics &amp; Comparison # Revenue from Operations (Q4 FY25): Rs. 442.02 crores, an increase of 20.01% YoY. Revenue from Operations (FY25): Rs. 2035.15 crores, an increase of 15.73% YoY. EBITDA (Q4 FY25): Stated as Rs. 1095.75 crores (this seems to be a typo in the transcript, likely meant Rs. 109.57 crores if Q4 EBITDA margin is 24.83% on Rs. 442.02 cr revenue. Assuming it’s Rs. 109.57 crores, up 37.03% YoY). EBITDA (FY25): Rs. 416.61 crores, up 27.23% YoY. EBITDA Margin (Q4 FY25): 24.83%, improved from 21.75% in Q4 FY24. EBITDA Margin (FY25): 20.47%, improved from 18.62% in FY24 (an improvement of 180 bps). Profit After Tax (PAT) (Q4 FY25): Rs. 75.5 crores, up 27.94% YoY. Profit After Tax (PAT) (FY25): Rs. 296.96 crores, up 24.2% YoY. PAT Margin (Q4 FY25): 17.08%, improved from 16.02% in Q4 FY24. PAT Margin (FY25): 14.59%, improved from 13.6% in FY24 (an increase of 99 bps). Revised Guidance/Forecasts # FY25 EBITDA Margin Guidance: Initial guidance was a 100 bps reduction, revised mid-year to 100 bps improvement, and delivered 180 bps improvement. FY26 Revenue Growth Guidance: “higher double digit growth”. FY26 EBITDA Margin Guidance: Expected to “remain on similar lines as this year [FY25]”. FY26 Gross Margin Guidance: Expecting a “hit of around 100 basis point in the year 25-26”. Areas of Growth # Overall revenue growth driven by existing product portfolio and increased B2B sales. Significant improvement in EBITDA and PAT margins. Volume vs. Value Growth (Q4 FY25): Volume growth ~19%, Value growth 20%. Volume vs. Value Growth (FY25): Volume growth ~18% (300 bps higher than value growth of ~15%). Dividend &amp; Buyback # Dividend: Recommended 100% dividend (Rs. 2 per equity share), absorbing Rs. 9.02 crores. Buyback: Completed buyback of 5 lakh shares at Rs. 2000 per share in Q2 FY25. Segment Performance # Zone-wise Turnover (Q4 FY25): North 34%, East 12%, West 20%, South 34%. Product Category-wise Turnover (Q4 FY25): Insecticides 38%, Fungicides 13%, Herbicides 32%, Others 17%. B2B Sales (FY25): ~9% of total revenue (Rs. 40 crores from Dahej included), up from ~4% in FY24. Strategic Initiatives &amp; Business Updates # Major Strategic Announcements # Acquisition of international rights for two fungicide molecules (iprovalicarb and triadimenol) from Bayer AG, Germany. This acquisition provides presence in over 20 countries, marking a step towards becoming a global agrochemical player. New Products, Services, or Markets Discussed # Bayer Molecules: Expected to contribute Rs. 110 crores revenue in FY26 (including India brand sales and international sales). Distribution takeover from Bayer starting October, India launch in May. New Fungicide from Dahej: A non-synthetic pyrethroid fungicide to be manufactured at Dahej, revenue expected from Q2 FY26 (approx. Rs. 10 crores in FY26). Planned Launches (FY26): Paddy herbicide (from Japan HoCo chemicals) in May, Japanese fungicide (from Nissan Chemicals) in next quarter. Grapes fungicide late next quarter. Significant Operational Changes # Aggressively increased presence in corporate (B2B) sales in the Indian market. Dahej Facility # FY25 Revenue: Rs. 40 crores. FY25 EBITDA: Negative Rs. 14 crores. FY26 Expected Revenue: Rs. 60 crores (including Rs. 10 crores from new fungicide). FY26 Expected EBITDA: Similar negative lines as FY25. Current Capacity Utilization (FY25): ~25%. Expected FY26: ~35%. EBITDA Breakeven Utilization: ~70-80%. Ongoing or Completed Projects # Strong R&amp;D division with NABL-accredited lab, focusing on new product registration and development. International collaborations with 10 leading global agrochemical companies. Investment in process research yielding good results with more products in the pipeline. Market &amp; Competitive Landscape # Industry Trends # Positive monsoon forecast (105% of LPA by IMD and SKYNET) creating positive sentiment for growers. India emerging as a key supply chain point for agrochemicals, especially with negative sentiments around China and trade wars. Increasing price trend in raw materials noted in the last quarter of FY25. Competitive Positioning Statements # “Dhanuka is working with the vision of transforming India through agriculture.” “Dhanuka’s, key focus has been on introduction of novel chemistry and extensive product development, distinguishing us from the rest of the industry.” Journey “from an Indian leader to a global agrochemical player” via Bayer molecules acquisition. Focus on differentiated products on the manufacturing side, similar to brand strategy. Market Challenges or Opportunities Mentioned # Opportunity: International market presents a “great opportunity for Dhanuka to expand our operations beyond the boundaries of India.” Challenge: International agrochemical market currently “behaving the way it is behaving” (implying some sluggishness). Opportunity: Brazil market for one of the acquired Bayer products has high entry barriers, which Dhanuka expects to maintain. Market Share or Positioning # Pan-India presence reaching over 10 million farmers. Network of ~6500 distributors and 80,000 retailers. B2B sales ramp-up is a strategic call to build channel for future products from Dahej and R&amp;D. Risk Factors &amp; Challenges # Dahej Facility Profitability: Currently running at a negative EBITDA of Rs. 14 crores (FY25) and expected to remain similar in FY26. Needs 70-80% utilization to break even. Raw Material Prices: Increasing trend in raw material prices, which the company intends to pass on to customers. This is expected to cause a 100 bps hit on gross margins in FY26. International Market Conditions: Acknowledged that the “international market obviously, is behaving the way it is behaving,” implying some headwinds. Trade Receivables: “trade receivables have gone up significantly.” Management stated they are in line with expectations and will come down in Q1. Forward-Looking Statements # Outlook and Future Projections # FY26 Revenue Growth: “higher double digit growth”. FY26 EBITDA Margin: “expected to remain on similar lines as this year [FY25]”. FY26 Gross Margin: Expected “hit of around 100 basis point”. Commitments or Targets Set by Management # Dahej Facility Revenue (FY26): Rs. 60 crores. Revenue from acquired Bayer molecules (FY26): Rs. 110 crores. Net economic benefit/royalty from Bayer arrangement (FY26): Rs. 15-20 crores. Overall Export Revenue (FY26, excluding Bayer products): Expected Rs. 60 crores (up from Rs. 30 Download Transcript">
  <meta property="og:locale" content="en_us">
  <meta property="og:type" content="article">
    <meta property="article:section" content="posts">
    <meta property="article:published_time" content="2025-05-19T19:14:58+00:00">
    <meta property="article:modified_time" content="2025-05-19T19:14:58+00:00">
    <meta property="article:tag" content="Dhanuka Agritech Ltd.">
    <meta property="article:tag" content="DHANUKA">
    <meta property="article:tag" content="Pesticides">
    <meta property="article:tag" content="Materials">
    <meta property="article:tag" content="Small Cap">
    <meta property="article:tag" content="Earnings Call">













<link rel="stylesheet" href="/assets/combined.min.722a154090e948dfc0b4cf97263194700c53c73fc095c249b60a5c9caddbbf84.css" media="all">




      <script async src="https://www.googletagmanager.com/gtag/js?id=G-T7PH4WNH24"></script>
      <script>
        var doNotTrack = false;
        if ( false ) {
          var dnt = (navigator.doNotTrack || window.doNotTrack || navigator.msDoNotTrack);
          var doNotTrack = (dnt == "1" || dnt == "yes");
        }
        if (!doNotTrack) {
          window.dataLayer = window.dataLayer || [];
          function gtag(){dataLayer.push(arguments);}
          gtag('js', new Date());
          gtag('config', 'G-T7PH4WNH24');
        }
      </script>




<script async src="https://pagead2.googlesyndication.com/pagead/js/adsbygoogle.js?client=ca-pub-3609399560636561" crossorigin="anonymous"></script>
</head>







<body class="light">
  <div class="content">
    <header>
      

<div class="header">

    
    <div id="search"></div>
</div>

    </header>
    <main class="main">
      





<div class="breadcrumbs">
    
    <a href="/">Home</a>
    <span class="breadcrumbs-separator"> > </span>
    
    <a href="/posts/">Posts</a>
    <span class="breadcrumbs-separator"> > </span>
    
    <a class="breadcrumbs-current" href="/posts/dhanuka-agritech-ltd---may-2025-earnings-call-transcript-analysis/">Dhanuka Agritech Ltd - May 2025 Earnings Call Transcript Analysis</a>
</div>



<div >

  <div class="single-intro-container">

    

    <h1 class="single-title" data-pagefind-body>Dhanuka Agritech Ltd - May 2025 Earnings Call Transcript Analysis</h1>
    

    

    <p class="single-readtime">
      
      
      
      <time datetime="2025-05-19T19:14:58&#43;00:00">May 19, 2025</time>
      

      
      &nbsp; · &nbsp;
      5 min read
      
    </p>

  </div>

  

  
  

  <div class="single-tags">
    
    <span>
      <a href="https://reports.muthu.co/tags/dhanuka-agritech-ltd./">#Dhanuka Agritech Ltd.</a>
    </span>
    
    
    <span>
      <a href="https://reports.muthu.co/tags/dhanuka/">#DHANUKA</a>
    </span>
    
    
    <span>
      <a href="https://reports.muthu.co/tags/pesticides/">#Pesticides</a>
    </span>
    
    
    <span>
      <a href="https://reports.muthu.co/tags/materials/">#Materials</a>
    </span>
    
    
    <span>
      <a href="https://reports.muthu.co/tags/small-cap/">#Small Cap</a>
    </span>
    
    
    <span>
      <a href="https://reports.muthu.co/tags/earnings-call/">#Earnings Call</a>
    </span>
    
    
  </div>

  
  

  

  
  <aside class="toc">
    <p><strong>Table of contents</strong></p>
    <nav id="TableOfContents">
  <ul>
    <li><a href="#earnings-call-transcript-analysis-report">Earnings Call Transcript Analysis Report</a></li>
    <li><a href="#financial-performance">Financial Performance</a>
      <ul>
        <li><a href="#key-financial-metrics--comparison">Key Financial Metrics &amp; Comparison</a></li>
        <li><a href="#revised-guidanceforecasts">Revised Guidance/Forecasts</a></li>
        <li><a href="#areas-of-growth">Areas of Growth</a></li>
        <li><a href="#dividend--buyback">Dividend &amp; Buyback</a></li>
        <li><a href="#segment-performance">Segment Performance</a></li>
      </ul>
    </li>
    <li><a href="#strategic-initiatives--business-updates">Strategic Initiatives &amp; Business Updates</a>
      <ul>
        <li><a href="#major-strategic-announcements">Major Strategic Announcements</a></li>
        <li><a href="#new-products-services-or-markets-discussed">New Products, Services, or Markets Discussed</a></li>
        <li><a href="#significant-operational-changes">Significant Operational Changes</a></li>
        <li><a href="#ongoing-or-completed-projects">Ongoing or Completed Projects</a></li>
      </ul>
    </li>
    <li><a href="#market--competitive-landscape">Market &amp; Competitive Landscape</a>
      <ul>
        <li><a href="#industry-trends">Industry Trends</a></li>
        <li><a href="#competitive-positioning-statements">Competitive Positioning Statements</a></li>
        <li><a href="#market-challenges-or-opportunities-mentioned">Market Challenges or Opportunities Mentioned</a></li>
        <li><a href="#market-share-or-positioning">Market Share or Positioning</a></li>
      </ul>
    </li>
    <li><a href="#risk-factors--challenges">Risk Factors &amp; Challenges</a></li>
    <li><a href="#forward-looking-statements">Forward-Looking Statements</a>
      <ul>
        <li><a href="#outlook-and-future-projections">Outlook and Future Projections</a></li>
        <li><a href="#commitments-or-targets-set-by-management">Commitments or Targets Set by Management</a></li>
      </ul>
    </li>
  </ul>
</nav>
  </aside>
  

  

  <div class="single-content">
    <h2 class="heading" id="earnings-call-transcript-analysis-report">
  Earnings Call Transcript Analysis Report
  <a class="anchor" href="#earnings-call-transcript-analysis-report">#</a>
</h2>
<h2 class="heading" id="financial-performance">
  Financial Performance
  <a class="anchor" href="#financial-performance">#</a>
</h2>
<h3 class="heading" id="key-financial-metrics--comparison">
  Key Financial Metrics &amp; Comparison
  <a class="anchor" href="#key-financial-metrics--comparison">#</a>
</h3>
<ul>
<li><strong>Revenue from Operations (Q4 FY25):</strong> Rs. 442.02 crores, an increase of 20.01% YoY.</li>
<li><strong>Revenue from Operations (FY25):</strong> Rs. 2035.15 crores, an increase of 15.73% YoY.</li>
<li><strong>EBITDA (Q4 FY25):</strong> Stated as Rs. 1095.75 crores (this seems to be a typo in the transcript, likely meant Rs. 109.57 crores if Q4 EBITDA margin is 24.83% on Rs. 442.02 cr revenue. Assuming it&rsquo;s Rs. 109.57 crores, up 37.03% YoY).</li>
<li><strong>EBITDA (FY25):</strong> Rs. 416.61 crores, up 27.23% YoY.</li>
<li><strong>EBITDA Margin (Q4 FY25):</strong> 24.83%, improved from 21.75% in Q4 FY24.</li>
<li><strong>EBITDA Margin (FY25):</strong> 20.47%, improved from 18.62% in FY24 (an improvement of 180 bps).</li>
<li><strong>Profit After Tax (PAT) (Q4 FY25):</strong> Rs. 75.5 crores, up 27.94% YoY.</li>
<li><strong>Profit After Tax (PAT) (FY25):</strong> Rs. 296.96 crores, up 24.2% YoY.</li>
<li><strong>PAT Margin (Q4 FY25):</strong> 17.08%, improved from 16.02% in Q4 FY24.</li>
<li><strong>PAT Margin (FY25):</strong> 14.59%, improved from 13.6% in FY24 (an increase of 99 bps).</li>
</ul>
<h3 class="heading" id="revised-guidanceforecasts">
  Revised Guidance/Forecasts
  <a class="anchor" href="#revised-guidanceforecasts">#</a>
</h3>
<ul>
<li><strong>FY25 EBITDA Margin Guidance:</strong> Initial guidance was a 100 bps reduction, revised mid-year to 100 bps improvement, and delivered 180 bps improvement.</li>
<li><strong>FY26 Revenue Growth Guidance:</strong> &ldquo;higher double digit growth&rdquo;.</li>
<li><strong>FY26 EBITDA Margin Guidance:</strong> Expected to &ldquo;remain on similar lines as this year [FY25]&rdquo;.</li>
<li><strong>FY26 Gross Margin Guidance:</strong> Expecting a &ldquo;hit of around 100 basis point in the year 25-26&rdquo;.</li>
</ul>
<h3 class="heading" id="areas-of-growth">
  Areas of Growth
  <a class="anchor" href="#areas-of-growth">#</a>
</h3>
<ul>
<li>Overall revenue growth driven by existing product portfolio and increased B2B sales.</li>
<li>Significant improvement in EBITDA and PAT margins.</li>
<li><strong>Volume vs. Value Growth (Q4 FY25):</strong> Volume growth ~19%, Value growth 20%.</li>
<li><strong>Volume vs. Value Growth (FY25):</strong> Volume growth ~18% (300 bps higher than value growth of ~15%).</li>
</ul>
<h3 class="heading" id="dividend--buyback">
  Dividend &amp; Buyback
  <a class="anchor" href="#dividend--buyback">#</a>
</h3>
<ul>
<li><strong>Dividend:</strong> Recommended 100% dividend (Rs. 2 per equity share), absorbing Rs. 9.02 crores.</li>
<li><strong>Buyback:</strong> Completed buyback of 5 lakh shares at Rs. 2000 per share in Q2 FY25.</li>
</ul>
<h3 class="heading" id="segment-performance">
  Segment Performance
  <a class="anchor" href="#segment-performance">#</a>
</h3>
<ul>
<li><strong>Zone-wise Turnover (Q4 FY25):</strong> North 34%, East 12%, West 20%, South 34%.</li>
<li><strong>Product Category-wise Turnover (Q4 FY25):</strong> Insecticides 38%, Fungicides 13%, Herbicides 32%, Others 17%.</li>
<li><strong>B2B Sales (FY25):</strong> ~9% of total revenue (Rs. 40 crores from Dahej included), up from ~4% in FY24.</li>
</ul>
<h2 class="heading" id="strategic-initiatives--business-updates">
  Strategic Initiatives &amp; Business Updates
  <a class="anchor" href="#strategic-initiatives--business-updates">#</a>
</h2>
<h3 class="heading" id="major-strategic-announcements">
  Major Strategic Announcements
  <a class="anchor" href="#major-strategic-announcements">#</a>
</h3>
<ul>
<li>Acquisition of international rights for two fungicide molecules (iprovalicarb and triadimenol) from Bayer AG, Germany.</li>
<li>This acquisition provides presence in over 20 countries, marking a step towards becoming a global agrochemical player.</li>
</ul>
<h3 class="heading" id="new-products-services-or-markets-discussed">
  New Products, Services, or Markets Discussed
  <a class="anchor" href="#new-products-services-or-markets-discussed">#</a>
</h3>
<ul>
<li><strong>Bayer Molecules:</strong> Expected to contribute Rs. 110 crores revenue in FY26 (including India brand sales and international sales). Distribution takeover from Bayer starting October, India launch in May.</li>
<li><strong>New Fungicide from Dahej:</strong> A non-synthetic pyrethroid fungicide to be manufactured at Dahej, revenue expected from Q2 FY26 (approx. Rs. 10 crores in FY26).</li>
<li><strong>Planned Launches (FY26):</strong> Paddy herbicide (from Japan HoCo chemicals) in May, Japanese fungicide (from Nissan Chemicals) in next quarter. Grapes fungicide late next quarter.</li>
</ul>
<h3 class="heading" id="significant-operational-changes">
  Significant Operational Changes
  <a class="anchor" href="#significant-operational-changes">#</a>
</h3>
<ul>
<li>Aggressively increased presence in corporate (B2B) sales in the Indian market.</li>
</ul>
<h4 class="heading" id="dahej-facility">
  Dahej Facility
  <a class="anchor" href="#dahej-facility">#</a>
</h4>
<ul>
<li>FY25 Revenue: Rs. 40 crores.</li>
<li>FY25 EBITDA: Negative Rs. 14 crores.</li>
<li>FY26 Expected Revenue: Rs. 60 crores (including Rs. 10 crores from new fungicide).</li>
<li>FY26 Expected EBITDA: Similar negative lines as FY25.</li>
<li>Current Capacity Utilization (FY25): ~25%. Expected FY26: ~35%.</li>
<li>EBITDA Breakeven Utilization: ~70-80%.</li>
</ul>
<h3 class="heading" id="ongoing-or-completed-projects">
  Ongoing or Completed Projects
  <a class="anchor" href="#ongoing-or-completed-projects">#</a>
</h3>
<ul>
<li>Strong R&amp;D division with NABL-accredited lab, focusing on new product registration and development.</li>
<li>International collaborations with 10 leading global agrochemical companies.</li>
<li>Investment in process research yielding good results with more products in the pipeline.</li>
</ul>
<h2 class="heading" id="market--competitive-landscape">
  Market &amp; Competitive Landscape
  <a class="anchor" href="#market--competitive-landscape">#</a>
</h2>
<h3 class="heading" id="industry-trends">
  Industry Trends
  <a class="anchor" href="#industry-trends">#</a>
</h3>
<ul>
<li>Positive monsoon forecast (105% of LPA by IMD and SKYNET) creating positive sentiment for growers.</li>
<li>India emerging as a key supply chain point for agrochemicals, especially with negative sentiments around China and trade wars.</li>
<li>Increasing price trend in raw materials noted in the last quarter of FY25.</li>
</ul>
<h3 class="heading" id="competitive-positioning-statements">
  Competitive Positioning Statements
  <a class="anchor" href="#competitive-positioning-statements">#</a>
</h3>
<ul>
<li>&ldquo;Dhanuka is working with the vision of transforming India through agriculture.&rdquo;</li>
<li>&ldquo;Dhanuka&rsquo;s, key focus has been on introduction of novel chemistry and extensive product development, distinguishing us from the rest of the industry.&rdquo;</li>
<li>Journey &ldquo;from an Indian leader to a global agrochemical player&rdquo; via Bayer molecules acquisition.</li>
<li>Focus on differentiated products on the manufacturing side, similar to brand strategy.</li>
</ul>
<h3 class="heading" id="market-challenges-or-opportunities-mentioned">
  Market Challenges or Opportunities Mentioned
  <a class="anchor" href="#market-challenges-or-opportunities-mentioned">#</a>
</h3>
<ul>
<li><strong>Opportunity:</strong> International market presents a &ldquo;great opportunity for Dhanuka to expand our operations beyond the boundaries of India.&rdquo;</li>
<li><strong>Challenge:</strong> International agrochemical market currently &ldquo;behaving the way it is behaving&rdquo; (implying some sluggishness).</li>
<li><strong>Opportunity:</strong> Brazil market for one of the acquired Bayer products has high entry barriers, which Dhanuka expects to maintain.</li>
</ul>
<h3 class="heading" id="market-share-or-positioning">
  Market Share or Positioning
  <a class="anchor" href="#market-share-or-positioning">#</a>
</h3>
<ul>
<li>Pan-India presence reaching over 10 million farmers.</li>
<li>Network of ~6500 distributors and 80,000 retailers.</li>
<li>B2B sales ramp-up is a strategic call to build channel for future products from Dahej and R&amp;D.</li>
</ul>
<h2 class="heading" id="risk-factors--challenges">
  Risk Factors &amp; Challenges
  <a class="anchor" href="#risk-factors--challenges">#</a>
</h2>
<ul>
<li><strong>Dahej Facility Profitability:</strong> Currently running at a negative EBITDA of Rs. 14 crores (FY25) and expected to remain similar in FY26. Needs 70-80% utilization to break even.</li>
<li><strong>Raw Material Prices:</strong> Increasing trend in raw material prices, which the company intends to pass on to customers. This is expected to cause a 100 bps hit on gross margins in FY26.</li>
<li><strong>International Market Conditions:</strong> Acknowledged that the &ldquo;international market obviously, is behaving the way it is behaving,&rdquo; implying some headwinds.</li>
<li><strong>Trade Receivables:</strong> &ldquo;trade receivables have gone up significantly.&rdquo; Management stated they are in line with expectations and will come down in Q1.</li>
</ul>
<h2 class="heading" id="forward-looking-statements">
  Forward-Looking Statements
  <a class="anchor" href="#forward-looking-statements">#</a>
</h2>
<h3 class="heading" id="outlook-and-future-projections">
  Outlook and Future Projections
  <a class="anchor" href="#outlook-and-future-projections">#</a>
</h3>
<ul>
<li>FY26 Revenue Growth: &ldquo;higher double digit growth&rdquo;.</li>
<li>FY26 EBITDA Margin: &ldquo;expected to remain on similar lines as this year [FY25]&rdquo;.</li>
<li>FY26 Gross Margin: Expected &ldquo;hit of around 100 basis point&rdquo;.</li>
</ul>
<h3 class="heading" id="commitments-or-targets-set-by-management">
  Commitments or Targets Set by Management
  <a class="anchor" href="#commitments-or-targets-set-by-management">#</a>
</h3>
<ul>
<li>Dahej Facility Revenue (FY26): Rs. 60 crores.</li>
<li>Revenue from acquired Bayer molecules (FY26): Rs. 110 crores.</li>
<li>Net economic benefit/royalty from Bayer arrangement (FY26): Rs. 15-20 crores.</li>
<li>Overall Export Revenue (FY26, excluding Bayer products): Expected Rs. 60 crores (up from Rs. 30</li>
</ul>



<div class="button-container">    
    <a href="https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=0377d95b-b87a-4993-92f7-70fb42b51159.pdf" target="_blank" class="report-button">
      <i class="fas fa-file-pdf"></i> Download Transcript
    </a>
</div>
    



    
  </div>

  


  

  
  

<div class="single-pagination">
    <hr />

    <div class="flex">

        <div class="single-pagination-prev">
            
            <div class="single-pagination-container-prev">
                <div class="single-pagination-text">←</div>
                <div class="single-pagination-text">
                    <a href="/posts/ventive-hospitality-ltd---may-2025-earnings-call-transcript-analysis/">
                        Ventive Hospitality Ltd - May 2025 Earnings Call Transcript Analysis
                    </a>
                </div>
            </div>
            
        </div>

        <div class="single-pagination-next">
            
            <div class="single-pagination-container-next">
                <div class="single-pagination-text">
                    <a href="/posts/raymond-ltd---may-2025-earnings-call-transcript-analysis/">
                        Raymond Ltd - May 2025 Earnings Call Transcript Analysis
                    </a>
                </div>
                <div class="single-pagination-text">→</div>
            </div>
            
        </div>

    </div>

    <hr />
</div>



  <div id="disqus_thread"></div>
<script>
    

    

    (function() { 
    var d = document, s = d.createElement('script');
    s.src = 'https://muthuai.disqus.com/embed.js';
    s.setAttribute('data-timestamp', +new Date());
    (d.head || d.body).appendChild(s);
    })();
</script>
<noscript>Please enable JavaScript to view the <a href="https://disqus.com/?ref_noscript">comments powered by Disqus.</a></noscript>
  

  

  
  <div class="back-to-top">
    <a href="#top">
      back to top
    </a>
  </div>
  

</div>


    </main>
  </div>

  <footer>
    

    
    
    
    <p>Made with ♥ in India</p>
    


  </footer>

  

</body>

<script>

  function isAuto() {
    return document.body.classList.contains("auto");
  }

  function setTheme() {
    if (!isAuto()) {
      return
    }

    document.body.classList.remove("auto");
    let cls = "light";
    if (window.matchMedia && window.matchMedia('(prefers-color-scheme: dark)').matches) {
      cls = "dark";
    }

    document.body.classList.add(cls);
  }

  function invertBody() {
    document.body.classList.toggle("dark");
    document.body.classList.toggle("light");
  }

  if (isAuto()) {
    window.matchMedia('(prefers-color-scheme: dark)').addListener(invertBody);
  }

  setTheme();

</script>
<script>
    window.addEventListener('DOMContentLoaded', (event) => {
        new PagefindUI({ element: "#search", showSubResults: false, showImages: false });
    });
</script>
<script defer src="/js/copy-code.js"></script>
</html>